
Children Webinar | Kawasaki Disease Beyond IVIg: What Is the Place for Additional Therapies?, 1 December 2026
A message from the webinar Chair:
Welcome to this webinar entirely dedicated to Kawasaki disease, one of the most common vasculitides in childhood and the leading cause of acquired heart disease in children in developed countries. While intravenous immunoglobulin has transformed outcomes, a meaningful proportion of patients are IVIg-resistant or present with coronary artery involvement that necessitates additional therapeutic strategies.
In this webinar, we will move beyond the classic lecture format: two young colleagues will first present an overview of the current evidence on corticosteroids, IL-1 inhibitors, and anti-TNF agents, followed by an open panel discussion with our experts on their respective roles in everyday clinical practice.
We intend this to be a genuinely useful, practice-oriented session, and we look forward to hearing your questions.
Date: Tuesday, 1 December 2026
Time: 12:00–13:20 EST | 18:00–19:20 CET
Webinar ID: 831 0681 7517
Webinar Secretariat: journal.webinar@mdpi.com
Webinar Announcement: sciforum.net/event/Children-13
Register now for free!
Program:
| Speaker/Presentation | Time (EST) | Time (CET) |
| Dr. Teresa Giani Chair Introduction |
12:00–12:05 | 18:00–18:05 |
| Dr. Giulia Inguscio and Dr. Irene Bellicini Part 1: Formal Presentations - Updates on Glucocorticoids and Biologic Treatments in Kawasaki Disease |
12:05–12:35 | 18:05–18:35 |
| Prof. Dr. Isabelle Koné-Paut, Dr. Nagib Dahdah and Dr. Marianna Fabi Part 2: Guided Debate - When to Use These Drugs, and in Which Patients |
12:35–13:05 | 18:35–19:05 |
| Q&A Session | 13:05–13:15 | 19:05–19:15 |
After registering, attendees will receive a confirmation email with information on how to join the webinar. Registrations with academic or institutional email addresses will be prioritized.
If you are unable to attend, feel free to register anyway, and we will let you know when the recording is available.
Webinar Chair and Keynote Speakers:
- Dr. Teresa Giani, Rheumatology Unit, AOU Meyer IRCCS Florence, Italy;
- Dr. Giulia Inguscio, Rheumatology Unit, AOU Meyer, IRCCS, Florence, Italy;
- Dr. Irene Bellicini, Department of Immunology-Rheumatology, CHU Saint-Justine, University of Montréal, Canada;
- Prof. Dr. Isabelle Koné-Paut, 1 Department of Pediatric Rheumatology and CEREMAIA, FHU Inflamme, ERN RITA member; 2 Bicêtre Hospital, APHP, and University of Paris Saclay, France;
- Dr. Nagib Dahdah, Division of Pediatric Cardiology, CHU Sainte-Justine, University of Montréal, Canada;
- Dr. Marianna Fabi, Pediatric Emergency Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, Italy.
